Articles related to ALZHEIMER'S/DEMENTIA

The recent study from CTAD 2023 has demonstrated the potential of p-tau217 as a promising biomarker for preclinical Alzheimer’s disease. This finding could significantly enhance our ability to detect Alzheimer’s at its earliest stages and initiate timely interventions.

Recent findings suggest that Candida albicans, a common fungus, can enter the brain and generate toxic protein fragments similar to those seen in Alzheimer’s disease. This discovery could potentially open new avenues for understanding and treating Alzheimer’s.

The discovery that irisin, an exercise-induced hormone, significantly reduces amyloid-β deposits opens up new therapeutic strategies for Alzheimer’s disease. This breakthrough underscores the importance of exercise and its far-reaching implications on cognitive health.

Discover how Labcorp’s new ATN Profile can revolutionize your approach to diagnosing Alzheimer’s disease.

Explore how prioritizing gut health may offer a head start advantage in combating neurodegenerative diseases.

Discover evidence-based lifestyle modifications that can help your patients possibly slow down dementia onset. Learn more about how physical activity, a healthy diet, and blood pressure management can play a crucial role in preventing this disease.